3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
155
INDUSTRY
145
NIH
26
OTHER_GOV
2
NETWORK
2
INDIV
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Genitourinary
1
Gastrointestinal
1
Conditions
Urinary Bladder Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Lung Neoplasms
1
Colorectal Neoplasms
1
Adenocarcinoma
1
Interventions
Proflavine
4
Microbial Collagenase
2
sargramostim
1
pembrolizumab
1
pegfilgrastim
1
macimorelin
1
keyhole-limpet hemocyanin
1
Sodium Chloride
1
Sirolimus
1
Peptides
1
Monatide (IMS 3015)
1
Ipilimumab
1
Gemcitabine
1
Everolimus
1
Biological Products
1
Bimatoprost
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
INDIV
×
Ipilimumab
×
Clear all
NCT03695835
2020-07-22
NIRPA
Gary Onik MD
Completed
27 enrolled